Table 1.
Baseline characteristics among patients according to serum uric acid levels.
| Normouricemia (n = 862) |
Asymptomatic Hyperuricemia (n = 232) |
p-Value | |
|---|---|---|---|
| Age (years) | 53.62 ± 12.61 | 59.04 ± 12.59 | <0.001 |
| Gender-males (%) | 518 (60.1%) | 143 (61.6%) | 0.669 |
| CV Risk factors | |||
| Current smokers (%) | 164 (19.0%) | 31 (13.4%) | 0.047 |
| Hypertension (%) | 491 (57.0%) | 183 (78.9%) | <0.001 |
| Dyslipidemia (%) | 749 (86.9%) | 194 (83.6%) | 0.201 |
| Diabetes (%) | 236 (27.4%) | 84 (36.2%) | 0.009 |
| Obesity (%) | 312 (36.2%) | 115 (49.6%) | <0.001 |
| Metabolic Syndrome (%) | 274 (31.8%) | 117 (50.4%) | <0.001 |
| Sedentary (%) | 278 (32.3%) | 90 (38.8%) | 0.062 |
| CV event (%) | 191 (22.2%) | 71 (30.6%) | 0.008 |
| Clinical and laboratory evaluation | |||
| SBP (mmHg) | 138.22 ± 17.74 | 141.99 ± 18.84 | 0.005 |
| DBP (mmHg) | 81.41 ± 10.04 | 80.00 ± 11.13 | 0.063 |
| PP (mmHg) | 56.80 ± 16.39 | 61.99 ± 18.53 | <0.001 |
| Total cholesterol (mg/dL) | 177.96 ± 41.86 | 170.22 ± 39.24 | 0.011 |
| LDL (mg/dL) | 99.40 ± 36.56 | 91.73 ± 34.05 | 0.003 |
| Triglyceride (mg/dL) | 137.86 ± 95.47 | 164.89 ± 100.66 | <0.001 |
| FPG (mg/dL) | 107.45 ± 28.15 | 116.53 ± 40.38 | 0.001 |
| HbA1C (%) | 6.01 ± 0.99 | 6.16 ± 0.94 | 0.035 |
| Drugs | |||
| Antihypertensive drugs (%) | 453 (53.6%) | 174 (75.0%) | <0.001 |
| Lipid-lowering drugs (%) | 667 (77.3%) | 169 (72.8%) | 0.149 |
| Antidiabetic drugs (%) | 218 (25.3%) | 79 (34.1%) | 0.008 |
| Traditional anthropometric indices | |||
| BMI (kg/m2) | 29.03 ± 4.96 | 30.68 ± 5.01 | <0.001 |
| WHR | 0.93 ± 0.09 | 0.96 ± 0.07 | <0.001 |
| WHtR | 0.60 ± 0.08 | 0.64 ± 0.08 | <0.001 |
| Novel anthropometric indices | |||
| ABSI | 0.082 ± 0.008 | 0.084 ± 0.007 | 0.001 |
| AVI | 20.17 ± 5.83 | 22.41 ± 5.48 | <0.001 |
| BAI | 32.45 ± 6.41 | 34.35 ± 7.97 | 0.001 |
| BRI | 5.62 ± 2.03 | 6.54 ± 2.22 | <0.001 |
| CI | 1.31 ± 0.13 | 1.36 ± 0.11 | <0.001 |
| CUN-BAE | 34.75 ± 7.91 | 36.97 ± 8.37 | <0.001 |
| WWI | 12.04 ± 1.00 | 12.10 ± 1.17 | 0.496 |
Data expressed as mean ± standard deviation and frequencies (%). Abbreviations: ABSI, a body shape index; AVI, abdominal volume index; BAI, body adiposity index; BMI, body mass index; BRI, body roundness index; CAD, coronary arterial disease; CI, conicity index; CUN-BAE, Clínica Universidad de Navarra-Body Adiposity Estimator; CV, cardiovascular; DBP, diastolic blood pressure; FPG, fast plasma glucose; HbA1c, glycated hemoglobin;LDL, low-density lipoprotein; PP, pulse pressure; SBP, systolic blood pressure; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; WWI, weight-adjusted waist index.